BioXpedia A/S and BioSkryb Genomics Announce European Partnership to Provide Groundbreaking, Single-Cell, Multiomic Analysis for Novel Target Identification and Therapeutic Development
This new partnership brings high-resolution, single-cell whole genome and whole transcriptome analysis to Europe. This partnership will enable novel insights and deep cellular characterization required in the evaluation, creation, and validation of new generation biologics and therapeutics in targeted disease management.
GelSight Mini enables an enhanced AI-enabled tactile experience for users in just five minutes out of the box.
ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-Cell Receptors
ImmunoScape, a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR-T-cell therapeutics announced that it has raised $14M in new financing.
Excision BioTherapeutics Doses First Participant in EBT-101 Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV
Excision BioTherapeutics announced that the first participant has been dosed in the Phase 1/2 clinical trial of EBT-101 for human immunodeficiency virus type 1 (HIV-1).
Xendee Releases New Features for Effectively Designing Sustainable Communities, Large Facilities, and Utility-Scale Microgrids
Xendee’s optimization software even takes into account cable length, losses through transferring energy, and the most efficient ways to generate and distribute energy from multiple energy sources at all hours of the day.
ImmunoScape announced that Dan MacLeod, Ph.D., the company’s vice president of discovery, will present at the 7th Annual CAR-TCR Summit taking place September 19-22, 2022 in Boston.
Liquid Instruments Raises $28.5 Million to Revolutionize Technology Development with Software-Defined Test Instrumentation
Growth investment accelerates product innovation, talent acquisition and expansion in commercial, educational markets
Excision BioTherapeutics Inc. announced that Excision Management will present at the following upcoming investor conferences.
Aldo Carrascoso, Co-Founder and CEO, and Erwin Estigarribia, COO, will present at the 20th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2022 in New York, NY
Seasoned CFO joins NTx with deep global experience in building financial systems for startups, venture capital, and investor relations
NUBURU, Inc., a Market Leader in Innovative Blue Laser Technology, Announces Successful Financing and the Completion of Other Significant Milestones
Successful issuance of over $5 million in convertible promissory notes to provide immediate capital to invest in the business
NanoCellect Biomedical Awarded $1.8M Federal Grant to Advance Imaging Flow Cytometry with Artificial Intelligence Technologies
Grant to continue the development of imaging flow cytometry technology to sort cells based on features derived from artificial intelligence
NUBURU Awarded SBIR Phase II Contract by U.S. Air Force to Develop Blue Laser-Based Area Printing Additive Manufacturing System
The next-generation 3D printing solution will utilize area printing technology with the aim of building metal parts up to 100x faster
NUBURU, Inc., a Leading Innovator in High Power and High Brightness Industrial Blue Laser Technology, to Go Public Through Merger With Tailwind Acquisition Corp.
NUBURU, Inc. (“NUBURU”) has entered into a business combination agreement with Tailwind Acquisition Corp. (“TWND”)
Brancieri joins NTx to oversee cGMP certification for the manufacturing and distribution of platform raw materials
GreenSpur Wind and Niron Magnetics Collaborate to Develop New Rare Earth-free Generator Solution for the Offshore Wind Market
GreenSpur designed a new, rare earth-free 15MW generator based on Niron’s magnet technology that delivers a 56% reduction in mass and meets required efficiency targets
Ron Dizy brings over 25 years of energy industry leadership across strategy, finance, operations, engineering, and business development to e-Zinc’s board
InterVenn Expands Global Presence to Drive the Potential of Glycoproteomics to Improve Patient Outcomes
The company’s new facilities add a large footprint of state-of-the-art laboratories and office space for scaling up InterVenn’s software development, technical support, clinical research and business development.
Nathan Duval, PhD, Lead Scientist, will present at the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) National Meeting
Following its Series A financing, BioFlyte welcomes national security and public safety executive Todd Sickles as CEO to accelerate productization and market penetration of its disruptive biodetection technology
Aspinity AML100 Solution Delivers Industry’s Best Battery Life/Accuracy Combo for Glass Break Sensors
Aspinity’s power-intelligent analogML solution named 2022 Best of Sensors Awards finalist
Fluent BioSciences and NanoCellect announce joint collaboration to improve resolution of single-cell RNA sequencing analysis of rare cell populations
Fluent and NanoCellect are able to leverage and combine the unique advantages of our respective technologies to expand the use of single-cell RNA sequencing for rare cell populations.
XENDEE Raises $12M Series A Financing to Accelerate Deployments of Net-Zero Distributed Energy Systems and Ultra-Fast EV Charging Infrastructure
A strong list of investors including TravelCenters of America Inc., Evergy Ventures, and Anzu Partners joined the oversubscribed $12M round
Several of NTx executives will attend the Biotechnology Innovation Organization (BIO) International Convention taking place at the San Diego Convention Center
With $32 Million in New Capital from Robert Bosch Venture Capital, Renesas, Anzu Partners and Arm, Arduino’s Vision for Universal Innovation Moves from the Garage and Classroom to the Enterprise With New Professional Offerings
InterVenn Biosciences Joins the WIN and FNIH Biomarker Consortiums to Introduce a Glycoproteomic Option for Liquid Biopsies
Networks will be instrumental in reaching patients and caregivers, making them aware of our platform and realizing its potential
InterVenn Biosciences Announces New Data Validating the Clinical Performance of DAWN™ IO Melanoma as a Novel Liquid Biopsy Test to Improve Assessment of Benefit to Cancer Patients
DAWN™ IO Melanoma is commercially available as a unique glycoproteomics laboratory-developed test (LDT) that aids Oncologists in planning treatment for Melanoma
BioSkryb Genomics Launches ResolveOME Early Access Program for Full Genome and Transcriptome Amplification From a Single Cell, in Conjunction With Its Innovative Bioinformatics Platform, BaseJumper™
BioSkryb launches an exclusive Early Access Program at AGBT 2022 for ResolveOME and BaseJumper, a bioinformatics platform to accelerate single-cell exploration
Paid demonstration will provide validation of commercial-scale e-Zinc long-duration energy storage system
GelSight Streamlines Inspection Workflows and Expands Analysis Capabilities in GelSight Mobile™ 2.4 Software Release
GelSight Mobile™ 2.4 enables new applications such as shot peening and corrosion inspection, while improving overall system performance
6K Additive’s sustainably produced powders will be qualified for full industrialization and high-volume production.
Consumers Can Access the Diabetes Risk Test Kit As Well As Other Health and Wellness Tests Through Labcorp OnDemand
Koch Strategic Platforms Leads $102M Series D Funding Investment in 6K To Accelerate Battery Material Production and Recycling
The investment is the first of two funding closes, expected to reach over $150M in total, aimed at building a low-cost, sustainable domestic supply chain for battery materials
GelSight will grow its presence in ten countries across Europe and Asia through four new distribution agreements
New financing will fuel international expansion and increase manufacturing capacity for its low power, sunlight-readable, and eye safe reflective LCD technology
Companies commence partnership to utilize NUBURU’s high power, high brightness blue laser technology and Essentium’s metal additive manufacturing platform to speed metal part production
CytoTronics Launches with $9.25 Million in Seed Funding to Revolutionize Drug Discovery and Phenotypic Screening
Harvard University spinout advances a unique complementary metal-oxide-semiconductor (CMOS)-powered drug discovery platform that opens a new dimension in cell-based screening
South 8 Technologies Raises $12M to Commercialize Next Generation Electrolytes for High Performance Lithium-ion Batteries
Financing from LG Technology Ventures, Shell Ventures, TNSC, Anzu Partners, and Foothill Ventures will help increase market adoption of the company’s proven Liquefied Gas Electrolyte technology
The financing will accelerate field validation and production of the BioTOF™ z200, a bio-aerosol detection system
Baker-Polito Administration Awards $1.5 Million Mass. Manufacturing Innovation Initiative Grant to North Andover’s 6K
Award from the Center for Advanced Manufacturing at MassTech will Fund High-Tech Equipment to Recycle Scrap Materials Used in Additive Manufacturing and Battery Production
InterVenn to Showcase Novel Translational Research Opportunities Based on Glycoproteomics at AACR 2022
InterVenn to Showcase Novel Translational Research Opportunities Based on Glycoproteomics at AACR 2022
e-Zinc Secures USD $25 Million in Series A Financing to Advance Long-Duration Energy Storage
Codetta Biosciences Announces $15 Million in Series A Financing
Funding will be utilized to expand commercial operations and support new product development
The new U.S. patent covers NTx’s inventive in vitro cell-free expression system that overcomes the cost and timeline challenges faced by traditional systems
Veteran Healthcare Executive and Reimbursement Expert Joins InterVenn Biosciences’ Board of Advisors
James Almas, MD, has joined the company’s Board of Advisors to advise on reimbursement strategy, health economics, coding, and other foundational activities required for commercialization of novel diagnostic tests for the clinical market.
Liquid Instruments Announces New Instruments and Enhancements for Moku:Go to Expand Use Cases and Transform Engineering Education
Moku:Go and Moku:Pro to Introduce New Capabilities and Improve Usability for Students, Scientists and Engineers
Three-time public company CFO joins NUBURU with deep experience in leading business transformation and optimization of financial processes on a global scale